For the first time in Israel: HMOs have begun treating Korona patients with medication

The drug Paxlobide was manufactured by Pfizer and has an efficiency of about 90% in preventing hospitalizations and deaths among the at-risk population with mild-to-moderate conditions.

So far it has been received by a few patients.

One patient: "This drug gives me hope that I can get through the corona relatively easily"

Meirav Cohen

02/01/2022

Sunday, 02 January 2022, 19:09 Updated: 19:29

• Share on Facebook

• Share on WhatsApp

• Share on Twitter

• Share on Email

• Share on general

• Comments

  Comments

In the video: Bennett refers at the cabinet meeting to an increase in morbidity data in Corona (Photo: GPO)

The shipment of the drug Paxlobid, which arrived in Israel last week (Photo: Flash 90, Avshalom Shashoni)

The HMOs began providing home medicine for the first time tonight (Sunday) to Corona patients in a mild-moderate condition.

The drug Paxlobide was manufactured by Pfizer and has an efficiency of about 90% in preventing hospitalizations and deaths among high-risk populations.

Four Maccabi HMO members have already received the medicine at home after they were found suitable for treatment by their doctors.

One of them is Ora Rosenzweig, a resident of Ramat Hasharon.

"There was great excitement ahead of the arrival of the drug," she said.

"I did three vaccines and still got Corona. Because I have a background illness I am very worried that my condition will get worse and I will get to the hospital. This drug gives me hope that I can get through Corona relatively easily. Even if there are some concerns about the drug, Corona damage ".

Good to know (promoted)

Doctors recommend: six minutes, twice a day and no pain

Served on behalf of Bee Cure Laser

Simcha Neumark, 33, from Jerusalem, is the first insured of the United HMO to receive the medicine at his home.

The drug came home special delivery came from the pharmacy chief of the unified Jerusalem, after talking with a doctor SCC of origin of the subsidiary and another conversation with the pharmacist explained to him how and when to take the medicine. The medicine would take Neumark for five days, at a dose of twice daily.

Director parable Meuhedet's Corona T., Dr. Erez Carmon, said that "the drug is given according to very specific labels and is intended to prevent the disease from getting worse in people who are at risk.

"There is no doubt that this is an exciting day and I sincerely hope that with its help we can reduce hospitalizations and reduce the number of deaths."

The FDA has approved the pill for patients 12 years of age and older with mild to moderate illness.

The U.S. Food and Drug Administration said the drug should be prescribed as soon as possible after diagnosis, and within five days of the onset of symptoms.

However, because in the beginning there will probably be deficiencies, in Israel the drug will be given to patients with background diseases or the elderly, as well as to people who are not vaccinated, since the vaccinated have better protection against a serious illness.

• news

• Corona

Tags

• Corona

• Omicron variant